Are you Dr. Lee?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 17 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
5301 Virginia Way
Suite 300
Brentwood, TN 37027Phone+1 615-221-4474Fax+1 615-234-3774- Is this information wrong?
Summary
- Dr. Michael Lee, MD is a dermatologist in Brentwood, Tennessee. He is currently licensed to practice medicine in Tennessee, Florida, and New Jersey. He is a Professor at University of Tennessee Health Science Center College of Medicine.
Education & Training
- Emory University School of MedicineResidency, Pathology-Anatomic and Clinical, 2009 - 2013
- NYU Grossman School of MedicineResidency, Pathology-Anatomic and Clinical, 1986 - 1990
- Taipei Medical UniversityClass of 1979
Certifications & Licensure
- NJ State Medical License 1994 - Present
- GA State Medical License 1994 - 2025
- TN State Medical License 2013 - 2017
- FL State Medical License 1996 - 2008
- NY State Medical License 1990 - 1994
- PA State Medical License 1993 - 1994
- American Board of Pathology Anatomic Pathology
- American Board of Pathology Dermatopathology
Publications & Presentations
PubMed
- 1 citationsHuman Polyomavirus 9-An Emerging Cutaneous and Pulmonary Pathogen in Solid Organ Transplant Recipients.Nischay Mishra, James Ng, Mark A Strom, Komal Jain, Riddhi Thakkar, Shreyas Joshi, Marcus Pereira, Lori Shah, Marc E Grossman, Michael J Lee, Simona De Michele, David ...> ;JAMA Dermatology. 2022 Mar 1
- Population differences in S-warfarin pharmacokinetics among African Americans, Asians and whites: their influence on pharmacogenetic dosing algorithms.Kubo, K.,Ohara, M.,Tachikawa, M.,Cavallari, L. H.,Lee, MTM.,Wen, M. S.,Scordo, M. G.,Nutescu, E. A.,Perera, M. A.,Miyajima, A.,Kaneko, N.,Pengo, V.,Padrini, R.,Chen, Y...> ;Pharmacogenomics J.. 2016 Aug 10
- Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for IFNL3 (IL28B) Genotype and PEG Interferon-α-Based Regimens.Muir, A. J.,Gong, L.,Johnson, S. G.,Lee, M. T.,Williams, M. S.,Klein, T. E.,Caudle, K. E.,Nelson, D. R.> ;Clin. Pharmacol. Ther.. 2013 Oct 08
- Join now to see all